Aetna reports 88% standardization of prior authorization volume
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
Aetna Announces Progress on Industry Leading Efforts To Simplify Prior Authorization
April 27, 2026 9:07 AM EDTHARTFORD, CT / ACCESS Newswire / April 27, 2026 / Originally published on CVS Health Company News
Aetna®, a CVS Health® company (NYSE:CVS), is setting the pace for prior authorization reform, moving faster and further to simplify access to care for patients and providers.
Aetna announced the company has already standardized 88% of its prior authorization volume, exceeding industry commitments, and continues to maintain the fewest medical services requiring prior authorization among national... More
